Afatinib Plus Bevacizumab Combination After Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR ‐Mutant Non–Small Cell Lung Cancer: Multicenter, Single‐Arm, Phase 2 Trial (ABC Study)

Cancer, EarlyView.

Source: Cancer - September 7, 2018 Category: Cancer & Oncology Authors: Akito Hata, MD , Nobuyuki Katakami, MD, PhD , Reiko Kaji, MD , Toshihide Yokoyama, MD , Toshihiko Kaneda, MD , Motohiro Tamiya, MD , Takako Inoue, MD , Hiromi Kimura, MD , Yukihiro Yano, MD , Daisuke Tamura, MD, PhD , Satoshi Morita, Source Type: research